Trulieve Cannabis Corp.
Trulieve Cannabis Corp. (TRUL.CN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
trul.cn · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Trulieve Cannabis Corp. (TRUL.CN) measures how much investors pay for each dollar of the company's trailing earnings. TRUL.CN's current PE ratio of N/A is calculated by dividing its stock price of $18.15 by its TTM earnings per share of -$0.42.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2016 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%38.0x
MedianQ3 · 75%205.8x
Max
At N/A, TRUL.CN's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Trulieve Cannabis Corp.You TRUL.CN | $3.1B | N/A | — | -$0.42 |
 Cresco Labs Inc. CL.CN | $471M | N/A | — | -$0.40 |
 Cronos Group Inc. CRON.TO | $1.5B | N/A | — | -$0.03 |
 Curaleaf Holdings, Inc. CURA.TO | $3.6B | N/A | — | -$0.93 |
 dentalcorp Holdings Ltd. DNTL.TO | $2.1B | N/A | — | -$0.31 |
 Extendicare Inc. EXE.TO | $3.1B | 18.86x | +7.5% | $1.13 |
 Green Thumb Industries Inc. GTII.CN | $2.9B | 16.23x | -7.5% | $0.50 |
Industry Average 2 peers with valid PE | — | 17.55x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.62 | — | |
2024-12-31 FY2024 | — | $-0.82 | — | |
2023-12-31 FY2023 | — | $-2.28 | — | |
2022-12-31 FY2022 | — | $-1.10 | — | |
2021-12-31 FY2021 | 205.83x | $0.13 | +261.9% | |
2020-12-31 FY2020 | 56.88x | $0.55 | +677.0% | |
2019-12-31 FY2019 | 7.32x | $1.62 | -61.6% | |
2018-12-31 FY2018 | 19.08x | $0.42 | — | |
2017-12-31 FY2017 | — | $-0.00 | — | |
2016-12-31 FY2016 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Trulieve Cannabis Corp. (TRUL.CN) measures how much investors pay for each dollar of the company's trailing earnings. TRUL.CN's current PE ratio of N/A is calculated by dividing its stock price of $18.15 by its TTM earnings per share of -$0.42.
Frequently asked questions
TRUL.CN pe ratio · 6 questionsTRUL.CN's current PE ratio is N/A as of 2026-06-08, based on a stock price of $18.15 and TTM EPS of -$0.42. Data sourced from Financial Modeling Prep via TRUL.CN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Trulieve Cannabis Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08